NICE recommended rimegepant in 2023 for treating migraine and preventing episodic attacks (between 4 and 14 migraines per month), and atogepant in 2024 for preventing both episodic and chronic ...

Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...

As CGRP-targeted therapies move into wider use, new data are beginning to clarify their role in special populations, the value of switching agents when one fails, and their long-term vascular safety.

Thirteen percent of Americans—about 38 million people—suffer from migraine, and every one of them has a different experience with the condition. Treatment has to be as individualized as they are.

Among pediatric patients with available data, 72.2% (13/18) reported consistent headache relief and 36% (9/25) reported consistent freedom from headache. The Food and Drug Administration (FDA) has ...

Slate Medicines’ antibody drug is designed to block PACAP, a protein associated with migraines.

When you buy through links on our articles, Future and its syndication partners may earn a commission. A GLP-1 agonist, the same class of drugs as Ozempic, may treat migraine, a study finds. | Credit: ...

Migraine sufferers are no strangers to major headaches. The onset of a migraine can be painful, disorienting and sometimes even debilitating. During National Migraine and Headache Awareness Month, Fox ...

Emgality is a monthly subcutaneous injection used to prevent episodic and chronic migraine. Migraine is a condition that causes intense throbbing or pulsating on one side of the head. Migraine may ...

Selecting a treatment plan to deal with acute migraine attacks can be like putting together a toolkit of possible therapies, individualized for each patient, one expert said. The toolkit should ...

Migraines are increasing in frequency and intensity among Americans: Could climate change be a reason? Although the number of Americans who have migraines has remained stable for the last 30 years, ...

Nerivio is a wireless remote electrical neuromodulation device that is self-applied to the upper arm. Among pediatric patients with available data, 72.2% (13/18) reported consistent headache relief ...